Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic tranexamic acid for reducing blood loss during caesarean section in women at high risk of postpartum haemorrhage
PACTR202605853075255Phase 1Recruiting
- Sponsor
- Federal Teaching Hospital Owerri
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid prophylaxis with Placebo (2 arms). Primary endpoints: Mean intraoperative blood loss and Change in hematocrit at 48 hours postoperatively. Started Apr 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202605853075255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605853075255.